To assess the efficacy of diclofenac sodium (DS) in controlling the postoperative inflammation after phocoemulsification with rigid IOL implants of 5.2 mm in dark brown irises. Fifty eight patients who enrolled in this prospective study had phacoemulsification with rigid IOL implants of 5.2 mm. They were administered topical diclofenac sodium 0.1 % postoperatively. Baseline inflammatory flare and cell count in the anterior chamber was evaluated by slit lamp examination under a 3 mm x 1 mm wide slit light beam the next postoperative day. Follow up assessments were carried out on the third day, and then 1, 4 and 6 weeks post operatively using the same evaluation procedure. There was a significant reduction of the baseline cell and flare count one week post operatively. At the end of 4 weeks, only 2% of the eyes showed a residual reaction of + 1 and that too resolved later. Six weeks postoperative assessment of cell/flare count showed complete resolution of activity in the anterior chamber in all cases. Diclofenac sodium 0.1% appears to be effective in controlling mild to moderate postoperative inflammation after phacoemulsification with rigid IOL implants in dark brown irises.